HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquify and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company's new platform deliverers personalized, tissue specific treatments with precision and control, and without the undesirable side effects of many of today's interventional and surgical modalities. HistoSonics is led by a team of experienced domain experts and industry leaders with offices in Ann Arbor, Michigan and Minneapolis, MN.

histotripsy ultrasound medical device noninvasive Cancer treatment Robotically Assisted Sonic Therapy (RAST)(tm) Medical devices Non-invasive tumor destruction Interventional oncology Interventional radiology Surgical robotics Non-invasive Non-Thermal Non-ionizing radiation Histotripsy Tissue sparing Robotically Assisted Sonic Therapy (RASTâ„ ) B2B Medical Equipment Medical and Hospital Equipment Medical Devices